MORE►
Colt Ventures
[Images via Venture Dallas]
Venture Dallas Names First Round of Speakers for 2024 Summit
by Quincy Preston | Oct 11, 2024
Featuring leaders like Jesse Draper of Halogen Ventures, Jim Lee of the Texas Stock Exchange, and Christopher Darby, former CEO of In-Q-Tel, the October 30 event at the Bush Center in Dallas will focus on emerging trends in sectors such as healthcare, national security, and the creator economy.
by Kevin Cummings |
Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE►
by Lance Murray |
Mar 27, 2020
The investment from multiple sources, including local early-stage investor Hunt Technology Ventures, is the largest funding round by a startup this year in Dallas-Fort Worth.
MORE►
